Journals / KONURALP TIP DERGİSİ / 2013 / Cilt: 5 - Sayı: 1

-

Birinci Basamakta Kardiyovasküler Hastalıklara Nonfarmakolojik Öneriler

Pages
50–52
Publication Date
2013-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In primary prevention and treatment of cardiovascular diseases and hypertension, non-pharmacological treatment, mainly diet and lifestyle changes, is of great importance

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In family medicine, management of cardiovascular diseases and hypertension displays some differences.
📊
Key Findings & Data:These differences arise from the fact that hypertension is a risk factor rather than a disease in which lifestyle changes are very important both for prevention and treatment as well as unique characteristics of primary care environment.
💡
Conclusion & Impact:In primary prevention and treatment of cardiovascular diseases and hypertension, non-pharmacological treatment, mainly diet and lifestyle changes, is of great importance
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kardiyovasküler Hastalık · Hipertansiyon · Aile

Abstract

In family medicine, management of cardiovascular diseases and hypertension displays some differences. These differences arise from the fact that hypertension is a risk factor rather than a disease in which lifestyle changes are very important both for prevention and treatment as well as unique characteristics of primary care environment. Therefore management of hypertension in primary care must have a wider perspective. In primary prevention and treatment of cardiovascular diseases and hypertension, non-pharmacological treatment, mainly diet and lifestyle changes, is of great importance

Özet

Aile hekimliğinde kardiyovasküler hastalıklar ve hipertansiyona yaklaşım belli farklılıklar içerir. Bu farklılıklar birinci basamak ortamının özelliklerine bağlı olarak geliştiği gibi doğrudan hipertansiyonun bir hastalıktan çok risk faktörü olmasından ve önlenmesi ya da tedavisinin temel olarak yaşam tarzı değişikliklerine dayanmasından hipertansiyon yönetimi daha zengin ve kapsamlı olarak ele alınmak Bu

🔖

Cite This Article

R, B. (2013). -. KONURALP TIP DERGİSİ, Cilt: 5 - Sayı: 1, 50–52. https://ajindex.com/articles/686851

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wolf-Maier K, Cooper RS, Banegas JR et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, United states. JAMA 2003; 289(18): 2363-69.
  2. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24(11): 987–1003.
  3. Martiniuk AL, Lee CM, Lawes CM, et al. for the Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia- Pacific region. J Hypertens 2007; 25(1): 73–9.
  4. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343): 1347–60.
  5. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalenceof hypertension: a systematic review. J Hypertens 2004; 22(1): 11–9.
  6. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence awareness treatment control of Hypertension in the adult US population. Data from the Health Examination Surveys 1960 to 1991. Hypertension 1995; 26(1): 60–9.
  7. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is Hypertension so frequently uncontrolled in secondary prevention? J Hypertens 2003; 21(6): 1199–205.
  8. Mancia G, Ambrosioni E, Agabiti-Rosei E, Leonetti G, Trimarco B, Volpe M. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005; 23(8): 1575–81.
  9. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24(2): 215–33.
  10. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10(5): 495–99.
  11. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 2001; 37(2): 187–93. Omvik P. How smoking affects blood pressure. Blood Press 1996; 5(2): 71–7.
  12. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. Br Med J 1994; 309(6959): 901–11.
  13. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort s